STOCK TITAN

Freshpet (FRPT) CEO William Cyr sells 94K shares, exercises 168K options

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Freshpet, Inc. CEO William B. Cyr reported a series of option exercises and share sales in Freshpet common stock. On May 15 and May 18, 2026, he exercised options to acquire a total of 168,000 shares at a $10.23 exercise price and sold 94,364 shares in open-market transactions.

The sales occurred at weighted average prices generally between about $47.81 and $51.68 per share. Following these transactions, Cyr holds 227,815 shares of common stock directly, with additional indirect holdings through his spouse and family trusts. The sales were effected under a Rule 10b5-1 trading plan adopted on November 5, 2025, and the options exercised were granted under the company’s 2014 Omnibus Incentive Plan and were fully vested as of December 31, 2020.

Positive

  • None.

Negative

  • None.
Insider Cyr William B.
Role Chief Executive Officer
Sold 94,364 shs ($4.64M)
Type Security Shares Price Value
Exercise Options to purchase common stock 62,369 $0.00 --
Exercise Options to purchase common stock 4,620 $0.00 --
Exercise Options to purchase common stock 9,030 $0.00 --
Exercise Options to purchase common stock 7,981 $0.00 --
Exercise Common Stock 62,369 $10.23 $638K
Sale Common Stock 32,344 $48.46 $1.57M
Sale Common Stock 1,526 $49.09 $75K
Sale Common Stock 7,513 $50.36 $378K
Sale Common Stock 1,309 $51.32 $67K
Exercise Common Stock 4,620 $10.23 $47K
Sale Common Stock 959 $50.04 $48K
Exercise Common Stock 9,030 $10.23 $92K
Sale Common Stock 1,874 $50.04 $94K
Exercise Common Stock 7,981 $10.23 $82K
Sale Common Stock 1,656 $50.04 $83K
Exercise Options to purchase common stock 62,369 $0.00 --
Exercise Options to purchase common stock 4,620 $0.00 --
Exercise Options to purchase common stock 9,030 $0.00 --
Exercise Options to purchase common stock 7,981 $0.00 --
Exercise Common Stock 62,369 $10.23 $638K
Sale Common Stock 6,104 $48.44 $296K
Sale Common Stock 36,289 $49.46 $1.79M
Sale Common Stock 300 $49.85 $15K
Exercise Common Stock 4,620 $10.23 $47K
Sale Common Stock 959 $49.09 $47K
Exercise Common Stock 9,030 $10.23 $92K
Sale Common Stock 1,874 $49.09 $92K
Exercise Common Stock 7,981 $10.23 $82K
Sale Common Stock 1,657 $49.09 $81K
Holdings After Transaction: Options to purchase common stock — 493,024 shares (Direct, null); Options to purchase common stock — 36,520 shares (Indirect, By Spouse); Common Stock — 227,815 shares (Direct, null); Common Stock — 19,206 shares (Indirect, By Spouse)
Footnotes (1)
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.81 to $48.74. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.81 to $49.80. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.83 to $49.89. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.89 to $48.88. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.90 to $49.46. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.98 to $50.94. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.03 to $51.68. The reporting person undertakes to provide to Freshpet, Inc., any security holders of Freshpet, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set in this Form 4. The options were issued pursuant to the Issuer's 2014 Omnibus Incentive Plan. These options are fully vested as of December 31, 2020.
Shares sold 94,364 shares Total common stock sales reported in Form 4
Options exercised 168,000 shares Total underlying common shares from option exercises
Exercise price $10.23 per share Exercise price for options to purchase common stock
Direct holdings after trades 227,815 shares Common stock held directly by William B. Cyr after transactions
Sale price range (low) $47.81 per share Lower end of reported weighted average sale price ranges
Sale price range (high) $51.68 per share Upper end of reported weighted average sale price ranges
10b5-1 plan adoption date November 5, 2025 Date CEO adopted Rule 10b5-1 trading plan
Option plan 2014 Omnibus Incentive Plan Plan under which exercised options were granted and fully vested
Rule 10b5-1 trading plan regulatory
"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported is a weighted average price. These shares were sold in multiple transactions at prices within stated ranges."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Options to purchase common stock financial
"Options to purchase common stock with a $10.23 conversion or exercise price were exercised into common shares."
2014 Omnibus Incentive Plan financial
"The options were issued pursuant to the Issuer's 2014 Omnibus Incentive Plan. These options are fully vested as of December 31, 2020."
non-derivative financial
"Common Stock transactions are listed as non-derivative, reflecting trades in the underlying shares."
derivative security financial
"Exercise or conversion of derivative security is cited for the option transactions."
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Cyr William B.

(Last)(First)(Middle)
C/O FRESHPET, INC.
1450 US-206

(Street)
BEDMINSTER NEW JERSEY 07921

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Freshpet, Inc. [ FRPT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Chief Executive Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/15/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/15/2026M62,369A$10.23208,139D
Common Stock05/15/2026S(1)6,104D$48.44(2)(9)202,035D
Common Stock05/15/2026S(1)36,289D$49.46(3)(9)165,746D
Common Stock05/15/2026S(1)300D$49.85(4)(9)165,446D
Common Stock05/18/2026M62,369A$10.23227,815D
Common Stock05/18/2026S(1)32,344D$48.46(5)(9)195,471D
Common Stock05/18/2026S(1)1,526D$49.09(6)(9)193,945D
Common Stock05/18/2026S(1)7,513D$50.36(7)(9)186,432D
Common Stock05/18/2026S(1)1,309D$51.32(8)(9)185,123D
Common Stock05/15/2026M4,620A$10.2315,545IBy Spouse
Common Stock05/15/2026S(1)959D$49.0914,586IBy Spouse
Common Stock05/18/2026M4,620A$10.2319,206IBy Spouse
Common Stock05/18/2026S(1)959D$50.0418,247IBy Spouse
Common Stock05/15/2026M9,030A$10.2341,044IBy Irrevocable Spousal Trust for Linda W. Cyr
Common Stock05/15/2026S(1)1,874D$49.0939,170IBy Irrevocable Spousal Trust for Linda W. Cyr
Common Stock05/18/2026M9,030A$10.2348,200IBy Irrevocable Spousal Trust for Linda W. Cyr
Common Stock05/18/2026S(1)1,874D$50.0446,326IBy Irrevocable Spousal Trust for Linda W. Cyr
Common Stock05/15/2026M7,981A$10.2338,809IBy Linda W. Cyr 2020 Irrevocable Trust for Descendants
Common Stock05/15/2026S(1)1,657D$49.0937,152IBy Linda W. Cyr 2020 Irrevocable Trust for Descendants
Common Stock05/18/2026M7,981A$10.2345,133IBy Linda W. Cyr 2020 Irrevocable Trust for Descendants
Common Stock05/18/2026S(1)1,656D$50.0443,477IBy Linda W. Cyr 2020 Irrevocable Trust for Descendants
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Options to purchase common stock$10.2305/15/2026M62,369 (10)09/06/2026Common Stock62,369$0555,393D
Options to purchase common stock$10.2305/18/2026M62,369 (10)09/06/2026Common Stock62,369$0493,024D
Options to purchase common stock$10.2305/15/2026M4,620 (10)09/06/2026Common Stock4,620$041,140IBy Spouse
Options to purchase common stock$10.2305/18/2026M4,620 (10)09/06/2026Common Stock4,620$036,520IBy Spouse
Options to purchase common stock$10.2305/15/2026M9,030 (10)09/06/2026Common Stock9,030$080,410IBy Irrevocable Spousal Trust for Linda W. Cyr
Options to purchase common stock$10.2305/18/2026M9,030 (10)09/06/2026Common Stock9,030$071,380IBy Irrevocable Spousal Trust for Linda W. Cyr
Options to purchase common stock$10.2305/15/2026M7,981 (10)09/06/2026Common Stock7,981$071,057IBy Linda W. Cyr 2020 Irrevocable Trust for Descendants
Options to purchase common stock$10.2305/18/2026M7,981 (10)09/06/2026Common Stock7,981$063,076IBy Linda W. Cyr 2020 Irrevocable Trust for Descendants
Explanation of Responses:
1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025.
2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.81 to $48.74.
3. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.81 to $49.80.
4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.83 to $49.89.
5. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.89 to $48.88.
6. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.90 to $49.46.
7. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.98 to $50.94.
8. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.03 to $51.68.
9. The reporting person undertakes to provide to Freshpet, Inc., any security holders of Freshpet, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set in this Form 4.
10. The options were issued pursuant to the Issuer's 2014 Omnibus Incentive Plan. These options are fully vested as of December 31, 2020.
/s/ Andrew Lampert, as attorney-in-fact for the Reporting Person05/19/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did Freshpet (FRPT) CEO William B. Cyr report?

William B. Cyr reported both option exercises and share sales. He exercised options for 168,000 Freshpet common shares at a $10.23 exercise price and sold 94,364 shares in open-market transactions at weighted average prices around the high-$40s to low-$50s.

How many Freshpet (FRPT) shares does the CEO hold after these Form 4 transactions?

After the reported trades, William B. Cyr holds 227,815 shares directly. The filing also shows additional indirect ownership through his spouse and several family trusts, which collectively maintain further positions in Freshpet common stock beyond his direct holdings.

At what prices did Freshpet (FRPT) CEO William B. Cyr sell shares?

The reported sales used weighted average prices between roughly $47.81 and $51.68. Individual transactions occurred within narrower ranges, such as $47.81–$48.74 and $51.03–$51.68, reflecting multiple open-market trades over two trading days.

What stock options did the Freshpet (FRPT) CEO exercise in this filing?

Cyr exercised options to purchase 168,000 shares at a $10.23 exercise price. These options were issued under Freshpet’s 2014 Omnibus Incentive Plan and were fully vested as of December 31, 2020, before being exercised into common stock.

Were the Freshpet (FRPT) CEO’s share sales under a Rule 10b5-1 plan?

Yes. The filing states the sales were effected under a Rule 10b5-1 plan. The plan was adopted on November 5, 2025, meaning the timing of the May 2026 sales was pre-arranged rather than decided at the moment of trading.

How many Freshpet (FRPT) shares did William B. Cyr sell in total?

The transaction summary reports 94,364 shares sold. These shares were sold across multiple open-market trades at various weighted average prices, as detailed in the footnotes, while Cyr simultaneously exercised options to acquire a larger number of shares.